Oruka Therapeutics has reported positive interim data from the ongoing EVERLAST-A Phase IIa trial evaluating ORKA-001 in patients with moderate-to-severe...
AstraZeneca has received approval from the FDA for the subcutaneous self-administration of Saphnelo using the Saphnelo pen for SLE.The post...
Sun Pharma has signed a definitive agreement to acquire Organon in a transaction with an enterprise valuation of $11.75bn in...
BrioHealth Solutions has secured conditional FDA approval to begin a clinical trial of its BrioVAD system in children diagnosed with...
Kyowa Kirin and Kura Oncology have begun a Japanese Phase II registrational study of ziftomenib in adult patients with r/r...
GE HealthCare has dosed the first patient in its Phase II/III LUMINA clinical trial for the investigational manganese-based MRI contrast...
CatalYm has commenced dosing the first subject in its Phase II/III VINCIT trial, assessing the safety and efficacy of its...
Cumberland Pharmaceuticals has agreed to sell its branded commercial drug portfolio to Canada-based Apotex for $100m in cash.The post Cumberland...
Philips has received the US FDA 510(k) clearance for its Rembra platform of scanning systems, which covers the Rembra CT,...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.